ASCO and NCCN have worked together to help clinicians and patients identify and treat the side effects of immunotherapy before they become dangerous. Doctor and patient advocate Laura Porter describes what to watch out for if you’re taking an immune checkpoint inhibitor, a type of immunotherapy, for cancer.
The 2018 Cancer Survivorship Symposium: Advancing Care and Research will address key issues in promoting well-being in people who have finished active cancer treatment, covering topics such as exercise, follow-up care in young adult survivors, and better support for sexual problems.
The 2018 Clinical Cancer Advances report of the American Society of Clinical Oncology has crowned an adoptive cell immunotherapy as its Advance of the Year. What is this innovative cancer treatment? What are the risks and benefits?
Many cancer treatments can cause hair loss (alopecia). Talking with your health care team, learning about resources and programs, and finding support in your community can help you cope with hair loss.
After androgen-deprivation therapy for prostate cancer, many couples are surprised by the physical and emotional changes that come into their relationship because of a lack of testosterone.
The mouth is a complex body part, and cancer treatment can affect it. Here are some tips for oral hygiene and keeping your mouth healthy before and during treatment.
In this podcast from the ASCO Educational Book, Dr. Judith A. Paice discusses the risks and benefits of using opioids for pain caused by cancer and its treatment.
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Today’s key research highlights include CAR T-cell therapy for multiple myeloma, immune checkpoint inhibitors for mesothelioma, and targeted therapy advances for non-small cell lung cancer and HER2-positive breast cancer.
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research released today covers how using a web-based system to report symptoms helps patients live longer, a shorter schedule of chemotherapy can be an option for certain people with colon cancer, and a targeted therapy may slow the growth of BRCA-related breast cancer.
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Here are some of today’s key research highlights, with a focus on enhancing survivors’ health.
